Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000545506 | SCV000630543 | uncertain significance | Gastrointestinal stromal tumor | 2022-12-21 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 458990). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with PDGFRA-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 4 of the PDGFRA protein (p.Ser4Phe). |
Ambry Genetics | RCV002350206 | SCV002641636 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-09-19 | criteria provided, single submitter | clinical testing | The p.S4F variant (also known as c.11C>T), located in coding exon 1 of the PDGFRA gene, results from a C to T substitution at nucleotide position 11. The serine at codon 4 is replaced by phenylalanine, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV004568754 | SCV005055171 | uncertain significance | Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal | 2024-01-04 | criteria provided, single submitter | clinical testing |